Literature DB >> 7525547

Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.

P A Staubs1, D R Reichart, A R Saltiel, K L Milarski, H Maegawa, P Berhanu, J M Olefsky, B L Seely.   

Abstract

The insulin receptor is known to interact with the SH2 domain proteins p85 (the regulatory subunit of phosphatidylinositol 3-kinase), Syp (a tyrosine phosphatase), and GAP (GTPase-activating protein). In this study, we mapped the insulin receptor binding sites for each of these proteins by examining the ability of phosphopeptides, corresponding to insulin receptor phosphorylation sites, and mutant insulin receptors to inhibit an insulin receptor-SH2 domain interaction. Precipitation of partially purified insulin receptors by glutathione S-transferase fusion proteins containing the N-terminal SH2 domains of p85 and GAP and both SH2 domains of Syp was demonstrated. The effect of the addition of each phosphopeptide on insulin receptor precipitation was tested. pY1322, the C-terminal insulin receptor peptide, inhibited insulin receptor precipitation by both p85- and Syp-GST. The NPXY internalization domain peptide inhibited insulin receptor precipitation by GAP-GST. These data were confirmed by mutant insulin receptor experiments. The insulin receptor C-terminal mutants, delta CT and Y/F2, were not precipitated by p85- or Syp-GST and the NPXY mutant insulin receptors, delta Ex16 and HI delta NPEY, were not precipitated by GAP-GST. Therefore, we conclude that p85 and Syp bind to the insulin receptor C terminus at tyrosine 1322 and GAP binds to the insulin receptor NPXY domain at tyrosine 960.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Signaling through receptors and scaffolds: independent interactions reduce combinatorial complexity.

Authors:  Nikolay M Borisov; Nick I Markevich; Jan B Hoek; Boris N Kholodenko
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

2.  Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes.

Authors:  D DePaolo; J E Reusch; K Carel; P Bhuripanyo; J W Leitner; B Draznin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.

Authors:  P Soni; M Lakkis; M N Poy; M A Fernström; S M Najjar
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Evidence for an insulin receptor substrate 1 independent insulin signaling pathway that mediates insulin-responsive glucose transporter (GLUT4) translocation.

Authors:  A J Morris; S S Martin; T Haruta; J G Nelson; P Vollenweider; T A Gustafson; M Mueckler; D W Rose; J M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.

Authors:  L Laviola; F Giorgino; J C Chow; J A Baquero; H Hansen; J Ooi; J Zhu; H Riedel; R J Smith
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Class I PI3K Biology.

Authors:  Tihitina Y Aytenfisu; Hannah M Campbell; Mayukh Chakrabarti; L Mario Amzel; Sandra B Gabelli
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

7.  Insulin inhibition of protein degradation in cells expressing wild-type and mutant insulin receptors.

Authors:  F G Hamel; J Fawcett; C I Andersen; P Berhanu; R G Bennett; W C Duckworth
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

8.  SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.

Authors:  K Kotani; P Wilden; T S Pillay
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

Review 9.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

10.  Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.

Authors:  Kenneth Siddle
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.